Shakir Tahir M, Fengli Liang, Chenguang Guo, Chen Niu, Zhang Ming, Shaohui Ma
Department of Radiology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Department of Radiology, Gansu Provincial Hospital, Lanzhou, China.
Acta Radiol Open. 2022 Feb 26;11(2):20584601221077068. doi: 10.1177/20584601221077068. eCollection 2022 Feb.
Noninvasive preoperative prediction of histological grading is essential for clinical management of cerebral glioma.
This study aimed to investigate the association between the image quality assessment of 1H magnetic resonance spectroscopy and accurate grading of glioma.
98 glioma patients confirmed by pathology were retrospectively recruited in this single-center study. All patients underwent 1H-MRS examination at 3.0T before surgery. According to WHO standards, all cases were divided into two groups: low-grade glioma (grade I and II, 48 cases) and high-grade glioma (grades III and IV, 50 cases). The metabolite ratios in both grades were calculated before and after image quality assessment. The area under the receiver operating characteristic (ROC) curve was used to evaluate the capacity of each ratio in glioma grading.
The Cho/Cr, Cho/NAA and NAA/Cr metabolite ratios had certain differences in each glioma group before and after MRS image quality assessment. In the low-grade glioma group, there was a dramatic difference in the Cho/Cr ratio before and after image quality assessment ( = 0.011). After MRS image quality assessment, the accuracy of glioma grading was significantly improved. The Cho/Cr ratio with 83.3% sensitivity and 93.7% specificity is the best index of glioma grading, with the optimal cutoff value of the Cho/Cr ratio being 3.72.
The image quality of MRS does affect the metabolite ratios and the results of glioma grading. MRS image quality assessment can observably improve the accuracy rate of glioma grading. The Cho/Cr ratio has the best diagnostic performance in differentiating high-grade from low-grade glioma.
脑胶质瘤的组织学分级术前无创预测对于临床治疗至关重要。
本研究旨在探讨氢质子磁共振波谱成像质量评估与胶质瘤准确分级之间的关联。
本单中心研究回顾性纳入98例经病理确诊的胶质瘤患者。所有患者在术前均接受3.0T氢质子磁共振波谱检查。根据世界卫生组织标准,将所有病例分为两组:低级别胶质瘤(Ⅰ级和Ⅱ级,48例)和高级别胶质瘤(Ⅲ级和Ⅳ级,50例)。在图像质量评估前后计算两组的代谢物比率。采用受试者操作特征(ROC)曲线下面积评估各比率在胶质瘤分级中的能力。
磁共振波谱成像质量评估前后,各胶质瘤组的胆碱/肌酸(Cho/Cr)、胆碱/ N - 乙酰天门冬氨酸(Cho/NAA)和N - 乙酰天门冬氨酸/肌酸(NAA/Cr)代谢物比率存在一定差异。在低级别胶质瘤组中,图像质量评估前后Cho/Cr比率有显著差异(P = 0.011)。磁共振波谱成像质量评估后,胶质瘤分级的准确性显著提高。Cho/Cr比率以83.3%的灵敏度和93.7%的特异度成为胶质瘤分级的最佳指标,Cho/Cr比率的最佳截断值为3.72。
磁共振波谱成像质量确实会影响代谢物比率及胶质瘤分级结果。磁共振波谱成像质量评估可显著提高胶质瘤分级的准确率。Cho/Cr比率在区分高级别与低级别胶质瘤方面具有最佳诊断性能。